Lobe Sciences Ltd.

CSE: LOBE

Company Logo

Company Overview

Lobe Sciences Ltd. is a growth-oriented research, technology, and services company that recently acquired Eleusian Biosciences Corp. The Company operates a portfolio of companies focused on developing transformational medicines and applies refined strategies to help partner companies. Lobe Sciences serves customers in Canada.

Financial Highlights

$888,531

Revenue (ttm)

$841,556

Gross Profit (ttm)

-$0.04

Diluted EPS (ttm)

Management Team

Mr. Jonathan R. Gilbert
Exec. Chairman

Mr. Philip J. Young
CEO, Corp. Sec. & Director

Mr. Brian Zasitko
Chief Financial Officer

Mr. Daniel S. McAtee
Chief Operating Officer

Mr. Maghsoud Dariani
Chief Science Officer

Sign Up for Alerts

Receive an email alert every time a company announces a merger, capital raise or files for an IPO.

Company Profile

Website

Twitter

Presentation

Key Highlights

Market Capitalization
$19,473,576

Shares Outstanding
199,733,984

Shares Short (% of Float)
681,360 (0%)

Insider Ownership
11%